IndianaSB 514First Regular Session 124th General Assembly (2025)Senate

Chimeric antigen receptor T-cell therapy.

Sponsored By: Jean Leising (Republican)

Failed

Summary

Provides that a policy of accident and sickness insurance or health maintenance organization contract that provides coverage for chimeric antigen receptor (CAR) T-cell therapy may not refuse to contract or deny coverage for the administration of any CAR T-cell therapy by any provider that qualifies as a certified health care facility by the federal Food and Drug Administration for the applicable CAR T-cell therapy.

health and provider services

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Jean Leising

    Republican • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. First reading: referred to Committee on Health and Provider Services

    1/16/2025Senate
  2. Authored by Senator Leising

    1/16/2025Senate

Bill Text

  • Introduced Senate Bill (S)

Related Bills

Back to State Legislation